Charles Stratton

Main researcher/physician at Vanderbilt University whose fundamental science and research, along with his colleagues, has formulated the combination antibiotic approach to treat Chlamydiae pneumoniae

Stratton/Mitchell & Siram Case Reports

Submitted by Jim K on Sat, 2006-01-21 20:33

Does it work?

It has been noted that most users of the combination antibiotic protocols commenting here have not been on the treatment long enough to give a big enough pool of reports to feel assured of the efficacy of this approach. I had asked Drs. Stratton, Wheldon, and Powell to perhaps tally up at least some basic numbers from their case experience to help us out with this problem, but this would involve problems of confidentiality and use of private data, etc.  

Then, I suddenly realized that we already have a good list of anecdotal reports of response to treatment reported data available to us... right in the Stratton/Mitchell patent materials! (Sheepish, embarrassed grin). So I took it as a project to summarize this data by disease treated. Occasionally I have used the exact wording from the patent materials as they were brief and descriptive. We have the full text referenced in our treatment and links if you want to see more detail.

All reported had with positive serology for Cpn using the highly sensitive tests developed by Stratton/Mitchell. I left out a few whose diagnosis was not clear to me, you can see them in the patent materials #6,884,784
All on some form of the combination antibiotic therapy protocol.

Stratton and colleagues, complete publications listing

Submitted by Jim K on Wed, 2005-08-31 19:50

This is a complete list of all publications written or co-authored by Charles Stratton. We've not had time to cull out only Cpn related references, but interested readers can scan for themselves. All we can say is.... he's been a very busy boy!

LABORATORY RESEARCH PUBLICATIONS

1. Stratton, C.W., Reller, L.B.: Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J. Infect. Dis. 136:187-195, 1977.

2. Reller, L.B., Stratton, C.W.: Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J. Infect. Dis. 136:196-204, 1977.

3. McKee, K.T., Wright, P.F., Gregg, C.R., Stratton, C.W.: Initial evaluation of kinetics and efficacy of moxalactam (LY 127935) in neonatal systemic gram-negative bacterial disease. Current Ther. Research 28:603-610, 1980.

Research by Stratton, et al

Submitted by Jim K on Wed, 2005-08-24 19:24

The absolute, complete list of references can be found here.

The following is a more selected set of references:

  • Sriram S, Stratton CW, Yao S, Tharp A, Bannan JD, Ding L, Mitchell WM. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Annals of Neurology, 46:6-14, 1999.
  • Alberts GL, Mitchell WM, Stratton CW, Franke JJ. Interstitial cystitis: can Chlamydia pneumoniae be a cause?. Infections in Urology, 16, 19-21, 2003
  • Sams HH, Mitchell WM, Stratton CW, King LE. Culture and immunhistochemical evidence of Chlamydia pneumoniae in pyoderma gangrenosum. Journal of the American Academy of Dermatology, 48, 966-969, 2003
  • Sriram S, Yao S, Mitchell WM, Calibresi P, Stratton CW, Ikejima H, Yamamoto Y. Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid from clinically definite and monosympomatic muliple sclerosis patinets. Clinical and Diagnostic Laboratory Immunology, 9, 1332-1337, 2003
  • Earlier Version of the Vanderbilt Protocol: Stratton, et al.

    Submitted by Jim K on Tue, 2005-08-23 22:10

    Please note: this is an earlier version of the Vanderbilt protocol developed by Dr. Stratton and his colleagues. It is here because it contains useful treatment info for reference. Please see Dr. Stratton's current protocol in the Cpn Handbbook. 

     

    Vanderbilt University has some of the world's experts on Cpn, and has been testing antibiotic treatment especially with MS. The Mitchell/Stratton, et al patent has highly detailed information about the testing and treatment they have developed, and can be found at this link.